Asthma

Showing NaN - NaN of 183

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Breath Washout, a Clinimetric Dataset

Recruiting
  • Cystic Fibrosis
  • +5 more
  • Multiple breath washout testing
  • London, United Kingdom
    Royal Brompton Hospital
May 5, 2022

Asthma Trial in Worldwide (Dupilumab)

Completed
  • Asthma
  • Birmingham, Alabama
  • +364 more
Mar 21, 2022

Asthma Trial in Hungary, South Africa, United Kingdom (Tezepelumab)

Recruiting
  • Asthma
  • Tezepelumab
  • Budapest, Hungary
  • +6 more
Mar 18, 2022

Asthma Trial in London, Manchester (TD-8236, Placebo)

Completed
  • Asthma
  • London, United Kingdom
  • +1 more
Feb 17, 2022

Asthma, COPD Trial in London, Manchester (MGR001, CRC749 inhaler)

Completed
  • Asthma
  • COPD
  • London, United Kingdom
  • +1 more
Feb 22, 2022

Asthma, Bronchial Diseases, Respiratory Tract Diseases Trial in Worldwide (Tezepelumab, Placebo)

Completed
  • Asthma
  • +8 more
  • Tezepelumab
  • Placebo
  • Denver, Colorado
  • +27 more
Feb 18, 2022

Asthma, COPD Trial in London, Manchester (SelK2 (Part 1), Placebo (Part 1), SelK2 (Part 2))

Completed
  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • SelK2 (Part 1)
  • +3 more
  • London, United Kingdom
  • +1 more
Feb 1, 2022

Asthma, Asthma Attack, Asthma Persistent Trial in London (ReferID)

Recruiting
  • Asthma
  • +3 more
  • ReferID
  • London, United Kingdom
    Guys and St Thomas NHS Foundation Trust
Jan 11, 2022

Asthma, Eczema, Constipation Trial in London (CYPHP Evelina London Model of care, Enhanced Usual Care)

Recruiting
  • Asthma
  • +2 more
  • CYPHP Evelina London Model of care
  • Enhanced Usual Care
  • London, United Kingdom
    Guy's and St Thomas' NHS Foundation Trust
Jan 19, 2022

Small Airways Physiology in Diseased and Healthy States

Completed
  • Asthma
  • +4 more
    • London, United Kingdom
      Airway Disease Section, National Heart and Lung Institute, Imper
    Nov 3, 2021

    Asthma Trial in London (QVM149, High Dose Dual Therapy (ICS/LABA))

    Withdrawn
    • Asthma
    • QVM149
    • High Dose Dual Therapy (ICS/LABA)
    • London, Ontario, Canada
      Robarts Research Insitute; The University of Western Ontario; Lo
    Nov 29, 2021

    Asthma Trial in Worldwide (Experimental: Tezepelumab, Placebo)

    Completed
    • Asthma
    • Experimental: Tezepelumab
    • Placebo
    • Dothan, Alabama
    • +288 more
    Oct 29, 2021

    Asthma Trial in Worldwide (Benralizumab (Medi-563), Placebo)

    Completed
    • Asthma
    • Benralizumab (Medi-563)
    • Placebo
    • Birmingham, Alabama
    • +212 more
    Oct 20, 2021

    Asthma, COPD Trial in London (Therapeutic Dose 1, Therapeutic Dose 2, Supra-therapeutic Dose)

    Completed
    • Asthma
    • Chronic Obstructive Pulmonary Disease
    • Therapeutic Dose 1
    • +3 more
    • London, Tooting, United Kingdom
      Richmond Pharmacology Ltd
    Oct 15, 2021

    Cancer, COPD, Asthma Trial in London (SELF-BREATHE)

    Recruiting
    • Cancer
    • +11 more
    • SELF-BREATHE
    • London, United Kingdom
      King's College Hospital NHS Foundation TRUST
    Sep 1, 2021

    High Dose Prednisolone Pharmacokinetics in Acute and Chronic

    Not yet recruiting
    • Thyroid Eye Disease
    • +4 more
    • No intervention - prednisolone is taken as part if routine clinical care.
    • London, United Kingdom
      Imperial College Healthcare NHS Trust
    Aug 11, 2021

    Asthma Trial in London (Bronchial challenge test)

    Recruiting
    • Asthma
    • Bronchial challenge test
    • London, United Kingdom
      Allergy Day Care Unite, Guy's Hospital
    Jul 27, 2021

    Asthma Trial in Worldwide (RELVAR/BREO, Salbutamol, Smart phone app)

    Completed
    • Asthma
    • Aventura, Florida
    • +65 more
    Mar 17, 2021

    Asthma Trial in Worldwide (CHF 5993 200/6/12.5 µg, CHF 1535 200/6 µg, CHF 1535 200/6 µg + Tiotropium Respimat 2.5 µg)

    Completed
    • Asthma
    • CHF 5993 200/6/12.5 µg
    • +2 more
    • Caba, Argentina
    • +243 more
    Apr 6, 2021

    Asthma Trial in Worldwide (CHF 5259 plus Foster 100/6 µg, Foster 100/6 µg)

    Completed
    • Asthma
    • CHF 5259 plus Foster 100/6 µg
    • Foster 100/6 µg
    • Dupnitza, Bulgaria
    • +43 more
    Apr 6, 2021

    Asthma Trial in Germany, United Kingdom (GSK2245035 Nasal Spray Solution, Placebo Nasal Spray Solution)

    Completed
    • Asthma
    • GSK2245035 Nasal Spray Solution
    • Placebo Nasal Spray Solution
    • Frankfurt, Hessen, Germany
    • +5 more
    Feb 26, 2021

    Asthma Trial in Canada, United States (drug, device, other)

    Completed
    • Asthma
    • Placebo DPI
    • +2 more
    • Little Rock, Arkansas
    • +18 more
    Feb 26, 2021

    Asthma Trial in Worldwide (FF/UMEC/VI (100/31.25/25) mcg, FF/UMEC/VI (100/62.5/25) mcg, FF/UMEC/VI (200/31.25/25) mcg)

    Completed
    • Asthma
    • FF/UMEC/VI (100/31.25/25) mcg
    • +10 more
    • Birmingham, Alabama
    • +408 more
    Feb 26, 2021

    Chronic Rhinosinusitis, Aspirin Exacerbated Respiratory Disease, Asthma Trial in London (Low salicylate diet, Normal Diet)

    Completed
    • Chronic Rhinosinusitis
    • +3 more
    • Low salicylate diet
    • Normal Diet
    • London, Ontario, Canada
      St. Joseph's Health Care
    Feb 17, 2021